GUTS

Fractyl Health, Inc. Common Stock GUTS

GUTS
Fractyl Health, Inc. Common Stock ADVM
Adverum Biotechnologies, Inc. ALXO
ALX Oncology Holdings Inc. DTIL
Precision BioSciences, Inc. ARTV
Artiva Biotherapeutics, Inc. STRO
Sutro Biopharma, Inc. QNCX
Quince Therapeutics, Inc. MGX
Metagenomi, Inc. Common Stock RPTX
Repare Therapeutics Inc. ATYR
aTyr Pharma, Inc.

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode GUTS ADVM ALXO DTIL ARTV STRO QNCX MGX RPTX ATYR
6M 8.98 % 77.24 % 188.84 % 2.24 % 66.67 % 22.53 % 194.41 % 15.73 % 45.58 % -85.19 %
YTD 5.40 % -9.17 % -5.13 % 6.82 % -66.90 % -49.27 % 123.94 % -56.33 % 62.12 % -80.30 %
1Y 6.40 % -17.11 % -3.90 % 5.70 % -68.27 % -52.71 % 120.42 % -46.78 % 33.75 % -74.58 %
3Y -82.53 % -30.90 % -86.81 % -86.42 % -72.50 % -86.95 % 521.77 % -83.95 % -85.60 % -55.48 %
5Y -82.53 % -96.89 % -98.15 % -97.92 % -72.50 % -95.49 % -86.01 % -83.95 % -94.58 % -55.48 %
10Y -82.53 % -94.78 % -95.07 % -99.04 % -72.50 % -93.56 % -87.20 % -83.95 % -93.05 % -55.48 %
From the beginning -82.53 % -98.44 % -95.07 % -99.04 % -72.50 % -93.56 % -87.20 % -83.95 % -93.05 % -55.48 %

Dividend